As the threat of a coronavirus disease 2019 (COVID-19) pandemic subsides, governments throughout the world are dealing with epidemic concerns due to the occurrence of monkeypox cases in various areas. Previously limited to African countries, the majority of monkeypox cases associated with the 2022 epidemic have been recorded in countries throughout Europe and the Western Hemisphere. While multiple organisations are doing contact-tracing operations, it is still unclear how this outbreak began. Monkeypox virus is one of several zoonotic viruses in the Orthopoxvirus genus of the Poxviridae family. Following the universal abolition of smallpox in the 1970s, monkeypox outbreaks drew international attention.The smallpox immunisation provided immunity against the monkeypox virus. Monkeypox cases rose when smallpox vaccine was halted. It wasn't until the 2003 US pandemic that monkeypox became well known. The virus did not originate in monkeys, despite the name "monkeypox." Although other rodents and small animals have been recognised as the virus's origins, the precise origin of monkeypox is uncertain. The viral infection was originally observed in macaque monkeys, thus the term monkeypox. Although human-to-human transmission of monkeypox is exceedingly rare, it is usually associated with respiratory droplets or direct contact with infected people's mucocutaneous sores. There is presently no treatment available for infected people; however, supportive therapies can be utilised to relieve symptoms; drugs such as tecovirimat may be used in severe cases. Many therapy are subjective since there are no unambiguous guidelines for symptom relief.

Orthopoxvirus, Poxviridae, Monkeypox, Zoonotic Disease, Corneal infection